All — ST PHARM

Science & Technology
- Business Overview
- CDMO
- CRO
  - AnaPath Research & Service
- R&D
  - Virtual R&D
  - Global R&D
About
Public
- PR (Public Relations)
  - News room
- IR (Investor Relations)
  - Stock Information
  - IR Library
Careers
ESG

Linkedin

Public

All

PR (Public Relations)
- News room
IR (Investor Relations)
- Stock Information
- IR Library

ST PHARM's Public Release

ST PHARM News[ST Pharm Leaflet] Generic APIOct 31, 2023

ST PHARM News[ST Pharm Leaflet] MonomerOct 31, 2023

ST PHARM News[ST Pharm Leaflet] Oligonucleotide CDMOOct 31, 2023

ST PHARM News[ST Pharm Leaflet] mRNA CDMO (SmartCap® STLNP®)Oct 31, 2023

ST PHARM NewsST Pharm Upcoming EventsOct 15, 2023

ST PHARM NewsST Pharm breaks ground on 2nd State-of-the-Art Oligonucleotide FacilitySep 19, 2023

ST PHARM News[Inovation Center Time lapse Movie]Mar 6, 2023

Media FocusST PHARM Cuts Joint Research Deal with Multiverse Pharma in the U.S.Feb 24, 2023

Media FocusST PHARM, signs $9.2million contract to supply MRI contrast medium raw materialsJan 11, 2023

ST PHARM NewsST PHARM participated in 2023 JP Morgan healthcare conferenceJan 4, 2023

ST PHARM NewsST PHARM, 2022 KCGS ESG rating 'B+'Dec 5, 2022

ST PHARM NewsST PHARM, 2022 Sustinvest ESG Rating 'AA'Nov 18, 2022

ST PHARM NewsST PHARM Participated in 10th International mRNA Health ConferenceOct 31, 2022

2of5